These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29666835)

  • 1. Aptamers and apple pies: a mini-review of PSMA aptamers and lessons from Donald S. Coffey.
    Lupold SE
    Am J Clin Exp Urol; 2018; 6(2):78-86. PubMed ID: 29666835
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen.
    Lupold SE; Hicke BJ; Lin Y; Coffey DS
    Cancer Res; 2002 Jul; 62(14):4029-33. PubMed ID: 12124337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-prostate-specific membrane antigen liposomes loaded with 225Ac for potential targeted antivascular α-particle therapy of cancer.
    Bandekar A; Zhu C; Jindal R; Bruchertseifer F; Morgenstern A; Sofou S
    J Nucl Med; 2014 Jan; 55(1):107-14. PubMed ID: 24337602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of prostate-specific membrane antigen recognition by the A9g RNA aptamer.
    Ptacek J; Zhang D; Qiu L; Kruspe S; Motlova L; Kolenko P; Novakova Z; Shubham S; Havlinova B; Baranova P; Chen SJ; Zou X; Giangrande P; Barinka C
    Nucleic Acids Res; 2020 Nov; 48(19):11130-11145. PubMed ID: 32525981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of prostate cancer using anti-PSMA aptamer A10-3.2-oriented lipid nanobubbles.
    Fan X; Guo Y; Wang L; Xiong X; Zhu L; Fang K
    Int J Nanomedicine; 2016; 11():3939-50. PubMed ID: 27574424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-aptamer-based delivery vehicle of doxorubicin to both PSMA (+) and PSMA (-) prostate cancers.
    Min K; Jo H; Song K; Cho M; Chun YS; Jon S; Kim WJ; Ban C
    Biomaterials; 2011 Mar; 32(8):2124-32. PubMed ID: 21147500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting tumor vasculature with aptamer-functionalized doxorubicin-polylactide nanoconjugates for enhanced cancer therapy.
    Tang L; Tong R; Coyle VJ; Yin Q; Pondenis H; Borst LB; Cheng J; Fan TM
    ACS Nano; 2015 May; 9(5):5072-81. PubMed ID: 25938427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural computational modeling of RNA aptamers.
    Xu X; Dickey DD; Chen SJ; Giangrande PH
    Methods; 2016 Jul; 103():175-9. PubMed ID: 26972787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paclitaxel-loaded and A10-3.2 aptamer-targeted poly(lactide-
    Wu M; Wang Y; Wang Y; Zhang M; Luo Y; Tang J; Wang Z; Wang D; Hao L; Wang Z
    Int J Nanomedicine; 2017; 12():5313-5330. PubMed ID: 28794625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced growth inhibition of prostate cancer in vitro and in vivo by a recombinant adenovirus-mediated dual-aptamer modified drug delivery system.
    Jing P; Cao S; Xiao S; Zhang X; Ke S; Ke F; Yu X; Wang L; Wang S; Luo Y; Zhong Z
    Cancer Lett; 2016 Dec; 383(2):230-242. PubMed ID: 27721020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rational truncation of an RNA aptamer to prostate-specific membrane antigen using computational structural modeling.
    Rockey WM; Hernandez FJ; Huang SY; Cao S; Howell CA; Thomas GS; Liu XY; Lapteva N; Spencer DM; McNamara JO; Zou X; Chen SJ; Giangrande PH
    Nucleic Acid Ther; 2011 Oct; 21(5):299-314. PubMed ID: 22004414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved Cancer Targeting by Multimerizing Aptamers on Nanoscaffolds.
    Omer M; Andersen VL; Nielsen JS; Wengel J; Kjems J
    Mol Ther Nucleic Acids; 2020 Dec; 22():994-1003. PubMed ID: 33251048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Administration and Targeted Radiosensitization via Chemically Synthetic Aptamer-siRNA Chimeras in Human Tumor Xenografts.
    Ni X; Zhang Y; Zennami K; Castanares M; Mukherjee A; Raval RR; Zhou H; DeWeese TL; Lupold SE
    Mol Cancer Ther; 2015 Dec; 14(12):2797-804. PubMed ID: 26438155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasound-mediated nanobubble destruction (UMND) facilitates the delivery of A10-3.2 aptamer targeted and siRNA-loaded cationic nanobubbles for therapy of prostate cancer.
    Wu M; Zhao H; Guo L; Wang Y; Song J; Zhao X; Li C; Hao L; Wang D; Tang J
    Drug Deliv; 2018 Nov; 25(1):226-240. PubMed ID: 29313393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficient delivery of micro RNA to bone-metastatic prostate tumors by using aptamer-conjugated atelocollagen in vitro and in vivo.
    Hao Z; Fan W; Hao J; Wu X; Zeng GQ; Zhang LJ; Nie SF; Wang XD
    Drug Deliv; 2016; 23(3):874-81. PubMed ID: 24892627
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA aptamer-mediated gene therapy of prostate cancer: lessons from the past and future directions.
    Arese M; Mahmoudian M; Bussolino F
    Expert Opin Drug Deliv; 2023; 20(11):1609-1621. PubMed ID: 38058168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of aptamers in prostate cancer: A systematic review of theranostic applications.
    Campos-Fernández E; Oliveira Alqualo N; Moura Garcia LC; Coutinho Horácio Alves C; Ferreira Arantes Vieira TD; Caixeta Moreira D; Alonso-Goulart V
    Clin Biochem; 2021 Jul; 93():9-25. PubMed ID: 33794195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Single Stranded DNA Aptamer as a Molecular Probe for LNCap Cells Using Cell-SELEX.
    Almasi F; Mousavi Gargari SL; Bitaraf F; Rasoulinejad S
    Avicenna J Med Biotechnol; 2016; 8(3):104-11. PubMed ID: 27563422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles.
    Dhar S; Gu FX; Langer R; Farokhzad OC; Lippard SJ
    Proc Natl Acad Sci U S A; 2008 Nov; 105(45):17356-61. PubMed ID: 18978032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A RNA-DNA Hybrid Aptamer for Nanoparticle-Based Prostate Tumor Targeted Drug Delivery.
    Leach JC; Wang A; Ye K; Jin S
    Int J Mol Sci; 2016 Mar; 17(3):380. PubMed ID: 26985893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.